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Abstract
Background: Deletions of the long arm of chromosome 18 cause a common autosomal syndrome clinically
characterized by a protean clinical phenotype.
Case presentation: We report on a 16-month-old male infant affected by fever attacks apparently unrelated with
any infectious or inflammatory symptoms, growth retardation, bilateral vertical talus, congenital aural atresia,
dysmorphisms, mild psychomotor delay, and peculiar neuroradiological features. Array-CGH analysis revealed one of
the smallest 18q22.3q23 interstitial deletions involving five genes: TSHZ1, ZNF516, ZNF236, MBP, and GALR1.
Conclusions: Herein we focus on previously unreported heralding symptoms and neuroradiological abnormalities
which enlarge the spectrum of 18q deletion syndrome demonstrating that a small deletion can determine a
complex phenotype.
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Background
Deletions of the long arm of chromosome 18 (18q-)
described by De Grouchy et al. [1] cause a common auto-
somal syndrome (1:40,000 live births) [2] characterized by a
wide range of phenotypic abnormalities related to the size
of the deletion and the position of breakpoints. Common
clinical features of the 18q- syndrome are short stature, fa-
cial dysmorphisms, foot deformities, congenital aural atresia
without microtia, variable intellectual disability, cerebral
white matter abnormalities, and microcephaly [3, 4]. Less
commonly reported features are kidney malformations,
bone dysplasia, growth hormone deficiency, congenital
heart disease (atrial or septal defect), and skin manifesta-
tions (dimpling and excessive whorls on fingertips) [5].
Besides cognitive impairment, neurological abnormalities
may include hypotonia, seizures, nystagmus, poor coordin-
ation, tremor, and choreoathetosis.
Several studies tried to define the specific regions
involved in each phenotypic trait and to identify possible
candidate genes [4, 6–11].
The advent of high-resolution microarray comparative
hybridization (aCGH) has allowed more precise pheno-
type/genotype correlations of such protean syndrome.
Interestingly, aCGH analysis performed in a series of 189
patients with deletions of chromosome 18q revealed that
none of the unrelated individuals shared the same
breakpoints, demonstrating a high level of variability and
genomic complexity surrounding deletions of 18q [12].
Herein we report a patient with one of the smallest
18q22.3q23 interstitial deletions described so far,
focusing on the heralding symptoms and the advanced
neuroradiological findings. These factors, together with
genetic assessment, can improve our knowledge about
this group of patients.
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Case presentation
We report the case of a 2-year-old male born at term after
an uneventful pregnancy from healthy unrelated parents
(Fig. 1). The family history was unremarkable. At birth his
weight was 2.990 kg (10th centile), length was 48 cm (6th
centile), and head circumference was 33 cm (6th centile).
Apgar scores were 8 and 9. Bilateral congenital vertical
talus was present at birth. Motor development was
delayed (autonomous sitting acquired at 13–14 months of
age). From the age of 5 months, the patient presented
long-term fever attacks with a continuous/sub-continuous
pattern and spikes up to 40–41 °C, apparently not associ-
ated with any infectious or inflammatory manifestation.
Acute phase reactants were persistently within normal
ranges. The only reported concomitant symptoms were
hyporexia and poor weight gain. Neither antipyretic nor
antibiotic treatment seemed to be effective.
At the age of 16 months the patient was admitted to our
Unit for fever of unrecognized origin. Physical examination
revealed growth impairment: weight was 7.83 kg (<3th
centile), length was 73 cm (<3th centile, SDS −2.5) with a
BMI of 14.7 (−2.3 SDS). Mild dysmorphic features were
present (i.e. frontal bossing, low-set ears), dental eruption
was regular although he showed mild organ enamel
dysplasia. Neurologic assessment showed global hypotonia,
hyperlaxity, hyporeflexia, and motor delay (he could only
walk with support). During hospitalization, we documented
recurrent abrupt fever spikes (up to 39 °C) lasting 3–5 days,
without any other systemic or local sign of inflammation or
infection. Fever attacks were well tolerated; skin hyperther-
mia and sweating were present too. Laboratory investiga-
tions showed inflammatory parameters within normal
ranges also during fever spikes, mild microcytic anaemia
(Hb 11.8 g/dl, MCV 72 fL), partial IgA deficiency (27 mg/
dl) with normal IgM and IgG, normal lymphocyte subpop-
ulations, and normal immune response against vaccines.
The infectious disease workout was negative: only once a
low degree bacteriuria (below 50.000 UFC/ml) was
incidentally found and antibiotic therapy (amoxicillin-clavu-
lanic acid) was started without any efficacy against the
fever. Abdominal and renal tract ultrasound scan, cystoma-
nometry, renal scintigraphy and voiding cystography, chest
X-ray, echocardiography, and single-contrast esophagogas-
troduodenal X-ray were also normal. Thyroid hormones,
acylcarnitine profile, plasma lactate, urinary catecholamine,
organic acid, and mevalonate urinary concentrations
resulted within normal ranges. Brain MRI showed diffuse
white matter signal hyperintensity on T2-weighted images
in keeping with delayed myelination. Visual evoked poten-
tials showed latency of cortical components at the upper
limit of normal ranges, and somatosensory evoked poten-
tials revealed a conduction velocity at the upper limit of
normal ranges for age with regular latency of cortical, sub-
cortical, cervical, and peripheral components in the upper
limbs. Ophthalmologic evaluation revealed high degree
myopia. Otologic examination disclosed stenosis of the
external auditory canals without structural abnormalities of
the pinna. Behavioural hearing assessment demonstrated
bilateral hearing impairment. CT scan of the temporal bone
confirmed bilateral atresia of the membranous portions and
marked stenosis of the bony portions of the external
auditory canals (Fig. 2).
At the age of 24 months, the patient was re-evaluated.
Growth impairment persisted: weight was 8.5 kg (<3th
centile), length was 82 cm (SDS −1.5) with a BMI of
12.6 (−4.3 SDS); psychomotor delay persisted (e.g.
walking was possible with an enlarged basis, no verbal
expression was reported). Notably, fever attacks had
spontaneously disappeared from the age of 20 months.
A follow-up brain MRI at this age demonstrated an
unchanged pattern of abnormal intensity of the white
matter on T2-weighted images (Fig. 3a).
Fig. 1 Picture of the patient performed at 14 months demonstrates
epicanthal folds, smooth philtrum, thin upper lip, low-set ears, prominent
frontal bossing and sparse light hair, carp-shaped mouth
Fig. 2 Temporal bone CT. Coronal (a) and axial (b) images reveal
marked stenosis and peculiar vertical orientation of the bony portions
of the external auditory canals (arrowheads) associated with rotation
and fusion of the malleus to the lateral middle ear cavity wall
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Results
Genetic study
Array-CGH analysis of the patient showed an interstitial
deletion at 18q22.3q23 spanning about 2.5 Mb of genomic
DNA from position 72,887,342 bp (clone A_16_P20921235)
to 75,418,267 (clone A_16_P41107360) flanked by probe
A_16_P20921038 (72,818,369 bp) and probe A_14_P133188
(75,452,546 bp) according to UCSC Genome Browser
(GRCh37/hg19 assembly) (Fig. 4). The deleted region con-
tains 5 OMIM genes: TSHZ1 (MIM 1614427, Teashirt zinc
finger homeobox), ZNF516 (MIM 615114, Zinc finger pro-
tein 516), ZNF236 (MIM 604760, Zinc finger protein-236),
Fig. 3 Brain MRI and MR spectroscopy performed at 24 months of age. a Axial T2-weighted image shows diffuse hyperintensity of the cerebral
white matter with relative sparing of the corpus callosum. Long TE spectroscopy (b) reveals an elevated choline peak (arrow), while short TE
spectroscopy (c) demonstrates a slightly increased myoinositol peak (arrow)
Fig. 4 Results of array-CGH analysis. a Chromosomal view. b Zoom view of long arm of chromosome 18 shows a 2.5 Mb deletion at 18q22.3q23
spanning from position 72,887,342 bp (clone A_16_P20921235) to 75,418,267 (clone A_16_P41107360) flanked by probe A_16_P20921038
(72,818,369 bp) and probe A_14_P133188 (75,452,546 bp) according to UCSC Genome Browser (hg19; GRChBuild 37.1, February 2009)
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MBP (MIM 159430, Myelin basic protein), GALR1 (MIM
600377, Galanin receptor 1). Array-CGH of the parents was
normal.
Neuroimaging data
Analysis of the DTI scalars revealed slightly lower
fractional anisotropy and higher mean, radial, and axial
diffusivity in the patient compared to controls in all the
assessed white matter regions. However, these differ-
ences were not statistically significant as assessed by
non-parametric Mann–Whitney test (Table 1).
MRS demonstrated normal N-acetyl aspartate, absent
lipids and lactate, and increased choline peak on the long
TE sequence with N-acetyl aspartate/creatine and cho-
line/creatine ratios of 2.18 and 1.79, respectively. On the
short TE sequence, slight increase of the myoinositol peak
was noted with N-acetyl aspartate/creatine and choline/
creatine ratios of 2.12 and 1.44, respectively (Fig. 3b, c).
Discussion
Here we describe the peculiar clinical phenotype and
neuroradiological features of a child harbouring an
uncommon 18q22.3q23 interstitial microdeletion.
To our knowledge, this is one of the smallest 18q
interstitial deletions described so far, including five
OMIM genes: TSHZ1, MBP, ZNF516, GALR1, and
ZNF236. Among these genes, TSHZ1 and MBP were
considered dosage-sensitive either with high or low
penetrance of the abnormal phenotype, the haploinsuffi-
ciency of ZNF516 and GALR1 seemed unrelated with
the clinical manifestations of 18q- syndrome, while the
consequences of a copy number change of ZNF236 are
still unknown [5] (http://www.pediatrics.uthscsa.edu/
centers/Chromosome18/dosage.asp). Only three other
patients harbouring a very similar deletion and similar
breakpoints have been reported [[3, 12], case 1; [13],
case 2]. Phenotypically, all showed dysmorphic features
and CAA, three patients showed intellectual disability
and only two a growth retardation (Table 2). Interest-
ingly, all of them shared the deletion of TSHZ1 and
MBP genes.
TSHZ1 gene is a member of the teashirt-type zinc-finger
protein family encoding putative zinc finger transcription
factors. Targeted inactivation in mouse resulted in a
neonatal lethal phenotype with soft palate clefting, vertebral
malformations, and abnormalities of the middle ear [14]. In
particular, the inactivation of Tshz1 seemed to lead to the
deregulation of Cbfa1 (RUNX2) in mesenchymal condensa-
tion, which allows the development of the tympanic ring.
Therefore, the hemizygosity of TSHZ1 gene was indicated
as a possible candidate for aural atresia in humans [13].
Recently, it has been demonstrated that deletion of TSHZ1
in mice leads to olfactory bulb hypoplasia and severe
olfactory impairment [15]. This gene has been proposed as
a candidate gene for congenital vertical talus (CVT) in a
study on three patients with 18q deletions [3]. Notably,
congenital aural atresia without microtia and CVT were
also found in our patient, thus supporting the hypothesis of
a pivotal role of TSHZ1 in the development of ears and feet
[[3, 12], case 1, [13], case 2].
MBP gene encodes a myelin basic protein that represents
one of the most important structural proteins of the myelin
sheath. In particular, MBP is thought to play a major role in
myelin compaction. Brain MRI studies in patients with
18q- syndrome typically showed diffuse white matter T2
hyperintensity with poor differentiation between gray and
white matter [16, 17]. These findings have been interpreted
as delayed or reduced myelin formation related to haploin-
sufficiency of the MBP gene. However, the precise patho-
genetic mechanisms underlying white matter abnormalities
in 18q- syndrome remain poorly understood. Loss of both
MBP genes in homozygous shiverer (shi) mice was histolog-
ically characterised by almost complete absence of myelin
in the central nervous system [18]. However, heterozy-
gous shiverer mice were found clinically normal with
normal myelin on brain MRI and pathological examin-
ation [19, 20]. Interestingly, a recent autopsy study on a
6-year-old boy with 18q- syndrome and abnormal white
matter on brain MRI revealed prominent astrogliosis with
normal myelin fibers and compact myelin sheaths [21].
Immunohistological examination revealed normal MBP
immunoreactivity in myelinated fibers, but reduced im-
munoreactivity in oligodendrocytes. The authors therefore
suggested that the signal abnormalities exhibited in 18q-
syndrome could reflect astrogliosis rather than hypomyeli-
nation [21]. This hypothesis is supported by the increase
Table 1 Diffusion Tensor Imaging data in the present patient compared with 5 age-matched controls
Mean fractional anisotropy (SD) Mean diffusivity (x10−3) (SD) Mean radial diffusivity (x10−3) (SD) Mean axial diffusivity (x10−3) (SD)
Patient Controls Patient Controls Patient Controls Patient Controls
CS 0.300 (0.091) 0.349 (0.019) 1.000 (0.100) 0.920 (0.044) 0.800 (0.100) 0.720 (0.044) 1.300 (0.100) 1.240 (0.054)
CC 0.622 (0.149) 0.637 (0.051) 1.100 (0.100) 0.920 (0.044) 0.700 (0.200) 0.520 (0.044) 1.900 (0.300) 1.700 (0.052)
PLIC 0.555 (0.115) 0.639 (0.017) 0.900 (0.100) 0.840 (0.054) 0.600 (0.100) 0.480 (0.044) 1.600 (0.200) 1.520 (0.109)
CWM 0.655 (0.069) 0.596 (0.087) 0.800 (0.100) 0.780 (0.054) 0.500 (0.100) 0.460 (0.083) 1.500 (0.200) 1.400 (0.173)
Pons 0.364 (0.135) 0.427 (0.063) 0.900 (0.100) 0.800 (0.030) 0.700 (0.100) 0.580 (0.044) 1.200 (0.100) 1.200 (0.070)
Legend: CC corpus callosum, CS centrum semiovale, CWM cerebellar white matter, PLIC posterior limb of internal capsule, SD standard deviation
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in choline, creatine, and myoinositol concentrations on
MR spectroscopy found in two patients with 18q- syn-
drome [22, 23], as well as in the present patient. These
findings suggest functional abnormalities of oligoden-
drocytes resulting in accelerated myelin turnover asso-
ciated with astrogliosis. Indeed, MR spectroscopy in
patients with Pelizaeus-Merzbacher disease, a represen-
tative hypomyelination disorder, typically shows de-
creased choline due to absence of myelin and mature
oligodendrocytes [24].
Diffusion tensor imaging (DTI), an advanced MRI
technique assessing the diffusion properties of white
matter water in vivo, has been used in the evaluation of
several congenital and acquired white matter disorders
[25]. On DTI, normal white matter tracts show high
diffusion anisotropy (fractional anisotropy, FA) with
higher diffusivity in the direction parallel to the fibers
(axial diffusivity, AD) than in the direction perpendicular
to them (radial diffusivity, RD). Increased RD values
were detected in mouse models of hypomyelination [20,
26, 27] and were interpreted as an indicator of myelin
density, since the absence of myelin facilitates movement
of water molecules perpendicular to the axons. Interest-
ingly, also human DTI studies indicated RD to be the
most sensitive among DTI parameters in distinguishing
patients with hypomyelinating disorders from controls
[25, 28]. To the best of our knowledge, DTI data have
never been reported in patients with 18q- syndrome.
Intriguingly, in the present patient, we did not find a
significant increase in RD compared to controls, which
reinforces the hypothesis of absent disruption of myelin
formation and/or compaction in this disorder. In this
regard, the consequences of haploinsufficiency of the
MBP gene in humans remain unknown and further
investigations are needed to elucidate the role of the
astroglia in 18q- syndrome.
GALR1 gene is involved in regulation of appetite and
pituitary hormone secretion, memory, learning, and
anxiety [29]. Intriguingly, this gene encodes the galanin
receptor GALR1 that mediates the hyperpolarisation of
the warm sensitive neurons in the preoptic area of the
hypothalamus. Warm sensitive neurons are involved in
changes of core body temperature during the fever
response [30]. Hence, we could speculate whether the
recurrent fevers in the present patient might be secondary
to GALR1 deficiency or dysfunction. Although our patient
showed teeth abnormalities suggestive of hypohidrotic
ectodermal dysplasia, no other clinical signs of this disease
were present. Notably ectodermal dysplasia-like findings
have been reported only in another child with 18q- syn-
drome [31]. So far, we are unable to state if the thermic
dysregulation in our patient is an occasional finding or a
18q- syndrome-related symptom: obviously further studies
on larger case series need to confirm this association.
ZNF516 and ZNF236 are zinc finger transcription
factors that could have important roles in the regulation
Table 2 The peculiar clinical phenotype and neuroradiological features of a child harbouring an uncommon 18q22.3q23 interstitial
microdeletion
Patients (coordinates) Growth
retardation
Dysmorphisms CAA Dysmielination Intellectual
disability
CVT Others Genes
Present case
Arr cgh18q22.3q23
(chr18:72887342–75418267)
2.531 Mb
Yes Epicanthal folds, long nasal
philtrum, thin upper lip,
low-set ears, prominent
frontal bossing and sparse
light hair
Yes Yes Yes Yes Recurrent fever ZADH2
TSHZ1
SMIM21
ZNF516
ZNF236
MBP
GALR1
[12]
Arr cgh 18q22.3q23
(chr18:70508757–74627485)
4.118 Mb
Yes bitemporal narrowing,
abnormal external ears
Yes Not reported Yes No Cleft soft palate ZNF407
ZADH2
TSHZ1
SMIM21
ZNF516
ZNF236
MBP
GALR1
[3] pat.1
Arr cgh 18q22.3q23
(chr18:72493281–74110482)
1.617 Mb
No prominent
epicanthal folds, depressed
nasal bridge,
Yes No Yes
(Speech
delay)
Yes ZNF407
ZADH2
TSHZ1
SMIM21
ZNF516
[13] pat.2
Arr cgh 18q22.3q23
(chr18:72.9–75.4)
2.5 Mb
No hypertelorism, midfacial
hypoplasia, and a broad
mouth with prominent lips
Yes Not reported No Yes Two sons with the same
clinical features of the
mother
TSHZ1
SMIM21
ZNF516
ZNF236
MBP
GALR1
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of other genes, but their influence in determining the
phenotype of our patient is still unclear.
Conclusion
In conclusion, the clinical features of our patient enlarge
the phenotypical spectrum of 18q deletion syndrome,
suggesting that even such small deletion can determine
a complex phenotype. Furthermore, the use of advanced
brain MRI technique, including DTI and MR spectros-
copy, may help to define the type of white matter
involvement and therefore improve our knowledge about
this interesting syndrome.
Materials and methods
Array-CGH analysis
Array-CGH analysis was performed on the patient and
his parents using Human Genome CGH Microarray Kit
G3 180 (Agilent Technologies, Palo Alto, USA) with ~13
Kb overall median probe spacing. Labelling and
hybridization were performed following the protocols
provided by the manufacturers. A graphical overview
was obtained using Agilent Genomic Workbench Lite
Edition Software 6.5.0.18.
Neuroimaging data
Diffusion Tensor Imaging (DTI) and MR spectroscopy
(MRS) studies were performed during the last MRI follow-
up on a 1.5 Tesla scanner (Achieva, Philips Medical
Systems, Best, The Netherlands). DTI data were acquired
using a single-shot spin-echo echoplanar imaging diffusion
sequence in 32 directions with TR/TE: 9318 ms/71 ms,
FOV: 224x224x120 mm, flip angle: 90°, 60 slices, acquisi-
tion voxel size: 2 × 2 × 2 mm, slice thickness: 2 mm, slice
gap: 0 mm, 2 b values of 0 and 800. DTI data were
processed using the FSL software package (Analysis Group
FMRIB, Oxford, United Kingdom) [32]. The fractional an-
isotropy (FA), mean diffusivity (MD), radial diffusivity
(RD), and axial diffusivity (AD) values were calculated
with a ROI-based approach in bilateral centrum semio-
vale, posterior limbs of internal capsule, corpus callosum,
cerebellar white matter, and pons using MIPAV (https://
mipav.cit.nih.gov/). These values were compared with
those obtained from 5 healthy age-matched infants with
normal MRI who were studied for headache, first seizure,
or minor trauma.
MRS with long and short TE was performed with the
point resolved excitation spin-echo sequence (PRESS
sequence; long TE: TR/TE = 2000/144 ms; short TE: TR/
TE = 2000/35 ms; voxel size 8 ml; 512 samples, 128
NSA). The measuring voxel was placed in the parieto-
occipital white matter.
Abbreviations
(18q-): Deletions of the long arm of chromosome 18; aCGH: High-resolution
microarray comparative hybridization; DTI: Diffusion tensor imaging;
MRS: Magnetic resonance spectroscopy
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